Antiplatelet treatment in primary and secondary stroke prevention in women

European Journal of Internal Medicine

Volumn 23, Issue 7, 2012, Pages 580-585

  Caso, Valeria ^a   Santalucia, Paola ^b   Acciarresi, Monica ^a   Pezzella, Francesca Romana ^c   Paciaroni, Maurizio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c AO S Camillo Forlanini   (Italy)

Author keywords

Antiplatelet agents; Primary prevention; Secondary prevention; Stroke; Women

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; CYCLOOXYGENASE 1; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR; NITRIC OXIDE; PLACEBO; TERUTROBAN; TICLOPIDINE; TRIFLUSAL;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; DEATH; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FOLLOW UP; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFORMATION RETRIEVAL; LOW DRUG DOSE; NEUTROPENIA; PEPTIC ULCER; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; SEX DIFFERENCE; STROKE; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VASCULITIS; WOMEN'S HEALTH;

EID: 84865684016     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.04.010     Document Type: Short Survey

References (46)

1. J. Bamford, P. Sandercock, M. Dennis, C. Warlow, L. Jones, and K. McPherson A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke J Neurol Neurosurg Psychiatry 51 1988 1373 1380
2. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
3. S. Seshadri, A. Beiser, M. Kelly-Hayes, C.S. Kase, R. Au, and W.B. Kannel The lifetime risk of stroke: estimates from the Framingham Study Stroke 37 2006 345 350
4. M.G. Bousser Stroke in women: the 1997 Paul Dudley White International Lecture Circulation 99 1999 463 467
5. J.M. Holroyd-Leduc, M.K. Kapral, P.C. Austin, and J.V. Tu Sex differences and similarities in the management and outcome of stroke patients Stroke 31 2000 1833 1837
6. M.K. Kapral, J. Fang, M.D. Hill, F. Silver, J. Richards, and C. Jaigobin Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network Stroke 36 2005 809 814
7. M. Niewada, A. Kobayashi, P.A. Sandercock, B. Kaminski, and A. Czlonkowska Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial Neuroepidemiology 24 2005 123 128
8. M.J. Reeves, C.D. Bushnell, G. Howard, J.W. Gargano, P.W. Duncan, and G. Lynch Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes Lancet Neurol 7 2008 915 926
9. C. Melloni, J.S. Berger, T.Y. Wang, F. Gunes, A. Stebbins, and K.S. Pieper Representation of women in randomized clinical trials of cardiovascular disease prevention Circ Cardiovasc Qual Outcomes 3 2010 135 142
10. J.W. Gargano, S. Wehner, and M. Reeves Sex differences in acute stroke care in a statewide stroke registry Stroke 39 2008 24 29
11. A.A. Ajayi, R. Mathur, and P.V. Halushka Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses Circulation 91 1995 2742 2747
12. M. Feuring, M. Christ, A. Roell, P. Schueller, R. Losel, and C.E. Dempfle Alterations in platelet function during the ovarian cycle Blood Coagul Fibrinolysis 13 2002 443 447
13. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. The Canadian Cooperative Study Group N Engl J Med 299 1978 53 59
14. P.A. Gum, K. Kottke-Marchant, E.D. Poggio, H. Gurm, P.A. Welsh, and L. Brooks Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 88 2001 230 235
15. B.T. Ivandic, E. Giannitsis, P. Schlick, P. Staritz, H.A. Katus, and T. Hohlfeld Determination of aspirin responsiveness by use of whole blood platelet aggregometry Clin Chem 53 2007 614 619
16. D.M. Becker, J. Segal, D. Vaidya, L.R. Yanek, J.E. Herrera-Galeano, and P.F. Bray Sex differences in platelet reactivity and response to low-dose aspirin therapy JAMA 295 2006 1420 1427
17. M.G. Bousser, E. Eschwege, M. Haguenau, J.M. Lefauconnier, N. Thibult, and D. Touboul The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results Rev Neurol (Paris) 139 1983 335 348
18. P.M. Ridker, N.R. Cook, I.M. Lee, D. Gordon, J.M. Gaziano, and J.E. Manson A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 2005 1293 1304
19. J.S. Berger, M.C. Roncaglioni, F. Avanzini, I. Pangrazzi, G. Tognoni, and D.L. Brown Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 2006 306 313
20. C. Baigent, L. Blackwell, R. Collins, J. Emberson, J. Godwin, and R. Peto Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
21. S.R. Seshasai, S. Wijesuriya, R. Sivakumaran, S. Nethercott, S. Erqou, and N. Sattar Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials Arch Intern Med 172 2012 209 216
22. E.L. Glader, B. Stegmayr, B. Norrving, A. Terent, K. Hulter-Asberg, and P.O. Wester Sex differences in management and outcome after stroke: a Swedish national perspective Stroke 34 2003 1970 1975
23. J.P. De La Cruz, M.A. Villalobos, P.J. Garcia, J.M. Smith-Agreda, and F. Sanchez de la Cuesta Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers Eur J Clin Pharmacol 47 1995 497 502
24. L.S. De Miguel, A. Jimenez, M. Monton, J. Farre, M. Del Mar Arriero, and J.A. Rodriguez-Feo A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function Eur J Clin Invest 30 2000 811 817
25. J. Matias-Guiu, J.M. Ferro, J. Alvarez-Sabin, F. Torres, M.D. Jimenez, and A. Lago Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial Stroke 34 2003 840 848
26. A. Culebras, R. Rotta-Escalante, J. Vila, R. Dominguez, G. Abiusi, and A. Famulari Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study Neurology 62 2004 1073 1080
27. W.K. Hass, J.D. Easton, H.P. Adams Jr., Phillips W. Pryse, B.A. Molony, and S. Anderson A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 321 1989 501 507
28. P.B. Gorelick, D. Richardson, M. Kelly, S. Ruland, E. Hung, and Y. Harris Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial JAMA 289 2003 2947 2957
29. M. Gent, J.A. Blakely, J.D. Easton, D.J. Ellis, V.C. Hachinski, and J.W. Harbison The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke Lancet 1 1989 1215 1220
30. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Lancet 348 1996 1329 1339
31. M. Acciarresi, P. De Rango, F.R. Pezzella, P. Santalucia, S. Amici, and M. Paciaroni Secondary stroke prevention in women Womens Health (Lond Engl) 7 2011 391 397
32. H.C. Diener, J. Bogousslavsky, L.M. Brass, C. Cimminiello, L. Csiba, and M. Kaste Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data Cerebrovasc Dis 17 2004 253 261
33. D.L. Bhatt, K.A. Fox, W. Hacke, P.B. Berger, H.R. Black, and W.E. Boden Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
34. The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group Lancet 2 1987 1351 1354
35. S. Deiner, J.H. Silverstein, and K.J. Abrams Management of trauma in the geriatric patient Curr Opin Anaesthesiol 17 2004 165 170
36. P.H. Halkes, J. van Gijn, L.J. Kappelle, P.J. Koudstaal, and A. Algra Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial Lancet 367 2006 1665 1673
37. J. Lokk Dipyridamole-associated headache in stroke patients- interindividual differences? Eur Neurol 62 2009 109 113
38. R.L. Sacco, H.C. Diener, S. Yusuf, D. Cotton, S. Ounpuu, and W.A. Lawton Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke N Engl J Med 359 2008 1238 1251
39. M. Cattaneo New P2Y(12) inhibitors Circulation 121 2010 171 179
40. M.G. Bousser, P. Amarenco, A. Chamorro, M. Fisher, I. Ford, and K.M. Fox Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial Lancet 377 2011 2013 2022
41. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group N Engl J Med 321 1989 129 135
42. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
43. L. Mosca, E.J. Benjamin, K. Berra, J.L. Bezanson, R.J. Dolor, and D.M. Lloyd-Jones Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association J Am Coll Cardiol 57 2011 1404 1423
44. K.L. Furie, S.E. Kasner, R.J. Adams, G.W. Albers, R.L. Bush, and S.C. Fagan Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke 62 2011 227 276
45. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 2008 457 507
46. H.C. Diener, L. Cunha, C. Forbes, J. Sivenius, P. Smets, and A. Lowenthal European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke J Neurol Sci 143 1996 1 13